{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:19:44Z","timestamp":1790936384746,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4496,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1997,1]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Five patients with non\u2010Hodgkin's lymphoma (NHL) and 4 patients with chronic lymphocytic leukaemia (CLL) were treated with the CDR\u2010grafted (rat \u00d7 human) monoclonal antibody (mAb) Campath\u20101H (anti\u2010CD52). Tumour regression was noted preferentially in peripheral blood and in the bone marrow but lymph nodes were less affected. Normal blood B and T cells were profoundly reduced in all patients whereas CD16<jats:sup>+<\/jats:sup> NK cells and CD14<jats:sup>+<\/jats:sup> monocytes decreased marginally. In all responding CLL patients CD52\u2010negative T but not B cells appeared during treatment and persisted for several months (4\u201319+) during unmaintained follow\u2010up. Clonal T cells defined as a predominance of a single T cell receptor (TCR) V gene usage, in one case verified by TCR CDR3 fragment analysis and nucleotide sequencing, emerged within the CD52<jats:sup>\u2013<\/jats:sup>\/CD8<jats:sup>+<\/jats:sup> cell population during Campath\u20101H therapy in 2 CLL patients, both achieving a long\u2010lasting remission. The increase in CD8<jats:sup>+<\/jats:sup> T cell expansions (up to 23\u2010fold) during unmaintained remission and follow\u2010up suggest that the clonal CD8<jats:sup>+<\/jats:sup> cells may represent regulatory T cells controlling the growth of the tumour B cell clone. Clonal T cells might thus be a target for an immune therapeutic intervention in B cell tumours.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1997.tb01403.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T10:45:27Z","timestamp":1279449927000},"page":"5-13","source":"Crossref","is-referenced-by-count":29,"title":["Clonal CD8<sub>+<\/sub> and CD52<sub>\u2013<\/sub> T cells are induced in responding B cell lymphoma patients treated with Campath\u20101H* (anti\u2010CD52)"],"prefix":"10.1111","volume":"58","author":[{"given":"A.","family":"\u00d6sterborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Halapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Harmenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wigzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Mellstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/332323a0"},{"key":"e_1_2_1_3_2","first-page":"449","article-title":"The antiglobulin response to therapeutic antibodies","volume":"2","author":"Isaacs JD","year":"1992","journal-title":"Semin Immunol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1990.tb01767.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.4.313"},{"key":"e_1_2_1_6_2","first-page":"305","article-title":"Removal of T cells from bone marrow for transplantation: comparison of rat monoclonal anti\u2010lymphocyte antibodies of different isotypes","volume":"1","author":"Hale G","year":"1983","journal-title":"Mol Biol Med"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90588-0"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6879183"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.4049\/jimmunol.134.5.3056","article-title":"Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody\u2010dependent cell\u2010mediated cytotoxicity with human lymphocytes","volume":"134","author":"Hale G","year":"1985","journal-title":"J Immunol"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(93)90155-5"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2787530"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000386035"},{"key":"e_1_2_1_13_2","first-page":"1250","article-title":"Towards a network theory of the immune system","author":"Jerne NK","year":"1974","journal-title":"Ann Immunol (Inst Pasteur)"},{"key":"e_1_2_1_14_2","first-page":"860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"311","author":"Carbone PP","year":"1971","journal-title":"Cancer Res"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V46.2.219.219"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.13.4937"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.9.4319"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1182\/blood.V77.8.1776.1776","article-title":"Predominant T cell receptor V gene usage in patient with abnormal clones of B cells","volume":"77","author":"Janson CH","year":"1991","journal-title":"Blood"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92294-P"},{"key":"e_1_2_1_20_2","first-page":"427","article-title":"Monoclonal rat anti\u2010human lymphocyte antibody Campath\u20101 binds to T and B lymphocytes but effectively lyses only T cells","volume":"2","author":"Gazitt Y","year":"1987","journal-title":"Bone Marrow Trans"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)93024-U"},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V73.6.1431.1431","article-title":"Effects of Campath\u20101 antibodies in vivo in patients with lymphoid malignancies: influence by antibody isotype","volume":"73","author":"Dyer MJS","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00200021"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1182\/blood.V86.4.1487.bloodjournal8641487","article-title":"Emergence of CD52\u2013, phosphatidylinositolglycan\u2010anchor\u2010deficient T lymphocytes after in vivo application of Campath\u20101H for refractory B\u2010cell non\u2010Hodgkin lymphoma","volume":"86","author":"Hertenstein B","year":"1995","journal-title":"Blood"},{"key":"e_1_2_1_25_2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4049\/jimmunol.152.3.1277","article-title":"Stimulation of tumor\u2010draining lymph node cells with superantigenic staphylococcal toxins leads to the generation ot tumor\u2010specific effector T cells","volume":"152","author":"Shu S","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.5.1863"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.4049\/jimmunol.153.6.2807","article-title":"Oligoclonality of tumor\u2010infiltrating lymphocytes from human melanomas","volume":"153","author":"Puisieux I","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s008940050001"},{"key":"e_1_2_1_29_2","first-page":"1824","article-title":"Tumor regression in monoclonal antibody\u2010treated patients correlates with the presence of anti\u2010idiotype\u2010reactive T lymphocytes","volume":"55","author":"Fagerberg J","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.171.3.659"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.4049\/jimmunol.153.9.4281","article-title":"T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions","volume":"153","author":"Farace F","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.4049\/jimmunol.152.10.4993","article-title":"TCR V beta 3+ and V beta 6+ CTL recognize tumor\u2010associated antigens related to HER2\/neu expression in HLA\u2010A2+ ovarian cancers","volume":"152","author":"Peoples GE","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.4049\/jimmunol.154.4.1804","article-title":"Accumulation of distinct T cell clonotypes in human solid tumors","volume":"154","author":"Yamamoto K","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(95)80082-4"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1997.tb01403.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1997.tb01403.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T05:03:41Z","timestamp":1698383021000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1997.tb01403.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["10.1111\/j.1600-0609.1997.tb01403.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1997.tb01403.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}